SFN and fragile X-associated tremor/ataxia syndrome: In fibroblasts from FXTAS patients, SFN has the potential to enhance pathways associated with brain function, bioenergetics, UPR, proteasome activity, antioxidant defenses, and iron metabolism, through NRF2-dependent and independent mechanisms [285].